
By unraveling the complex choreography of cellular machinery, Michigan State University (MSU) researchers are helping identify the next generation of drug targets and cancer therapies. Led by Jian Hu, PhD, and Kenneth Merz, PhD, the MSU team has unveiled new insights into a family of proteins that, while vital for cellular functions, are also linked to an array of diseases such as breast, ovarian, and pancreatic cancers. Understanding these dynamic proteins found in cell membranes β called Zrt-/Irt-like proteins, or ZIPs for short β will contribute to the search for cutting-edge drug therapies and the improved health of patients. βThe hope is to develop an inhibitor against this protein,β said Hu, a Professor in the Departments of Biochemistry and Molecular Biology, and Chemistry.
